Institut für Klinische Pharmakologie

Institut für Klinische Pharmakologie Bobenheim (IKP Bobenheim) is a specialized German contract research organization (CRO) focusing on early-phase clinical drug development and bioanalytical services. Established in 1992, the company provides comprehensive support for Phase I and IIa clinical trials, with core expertise in pharmacokinetics, pharmacodynamics, and bioequivalence studies. IKP Bobenheim is widely recognized for its high-quality analytical data generation, utilizing advanced technologies such as LC-MS/MS to support global regulatory submissions for both innovative therapeutics and complex generics. As a key member of the SocraTec group, the institute offers integrated solutions ranging from clinical protocol design to final regulatory reporting. The company maintains strict adherence to international GLP and GCP standards, serving a diverse client base of pharmaceutical and biotechnology firms.